Chronic exposure to trichothecenes is known to disturb insulin-like growth factor 1 and signaling of insulin and leptin hormones and causes considerable growth retardation in animals. However, limited information was available on mechanisms underlying trichothecene-induced growth retardation. In this study, we employed an integrated transcriptomics, proteomics, and RNA interference (RNAi) approach to study the molecular mechanisms underlying trichothecene cytotoxicity in rat pituitary adenoma GH3 cells. Our results showed that trichothecenes suppressed the synthesis of growth hormone 1 (Gh1) and inhibited the eukaryotic transcription and translation initiation by suppressing aminoacyl-tRNA synthetases transcription, inducing eukaryotic translation initiation factor 2-alpha kinase 2 (EIF2AK2) and reducing eukaryotic translation initiation factor 5 a. The sulfhydryl oxidases , protein disulfide isomerase,and heat shock protein 90 (were greatly reduced, which resulted in adverse regulation of protein processing and folding. Differential genes and proteins associated with a decline in energy metabolism and cell cycle arrest were also found in our study. However, use of RNAi to interfere with hemopoietic cell kinase (Hck) and EIF2AK2 transcriptions or use of chemical inhibitors of MAPK, p38, Ras, and JNK partially reversed the reduction of Gh1 levels induced by trichothecenes. It indicated that the activation of MAPKs, Hck, and EIF2AK2 were important for trichothecene-induced growth hormone suppression. Considering the potential hazards of exposure to trichothecenes, our findings could help to improve our understanding regarding human and animal health implications.
Trichothecene mycotoxins are a family of over 200 sesquiterpene epoxides (Grove, 2007) produced by food-borne and environmental fungi. These potent ribotoxins cause adverse health effects in humans and animals (Pestka and Smolinski, 2005) . Trichothecene mycotoxins are of great importance because they are commonly found in cereal-based foods (Eriksen and Pettersson, 2004; Foroud and Eudes, 2009) and are difficult to degrade during processing (Beyer et al., 2009; Bretz et al., 2005 Bretz et al., , 2006 . Diet consumption of these toxins results in adverse health effects such as growth retardation, feed refusal, reduced ovarian function and reproductive disorders, immunocompromised, intestinal epithelial barrier disruption, and vomiting in both animals and humans (Pinton and Oswald, 2014; Rocha et al., 2005; Wu et al., 2010) . Of the various toxic effects of trichothecenes, their capacity to impair growth in rodents and farm animals has been assessed risks associated with exposure to these compounds (JECFA 56th, 2001; JECFA 72nd, 2010) . Furthermore, anorexic effects of trichothecene, which lead to weight loss, possibly mediated via brain because previous studies have proved the effect of trichothecenes on the structure and neurochemistry of brain. After intravenous administration, deoxynivalenol (DON) was rapidly detected (<2.5 min) in the cerebral spinal fluid of swine and sheep (Prelusky et al., 1990) . Concentration of DON in the brain reaches a maximum level within 5-10 min in sheep and 30-60 min in swine.
Similarly, DON has been detected in the brains of laying hens, broiler hens, rats, and mice after acute or chronic exposure (Pestka, 2008; Prelusky et al., 1989; Wan et al., 2014) . Further, DON and T-2 toxin have resulted in an increased level of serotonin and its metabolites (Prelusky, 1996 (Prelusky, , 1997 Prelusky et al., 1992) and enhanced the anorectic and emetic responses of serotonin receptor antagonists in animals (Prelusky and Trenholm, 1993) . Most importantly, recent evidence showed that the centrally injected DON was able to reproduce anorexia that observed after per os intoxication at doses which was ineffective at the periphery, and it reached the brain where it modifies anorexigenic balance (Girardet et al., 2011) .
Modulation of hormones such as insulin-like growth factor 1 (IGF-1), IGF acid-labile subunit (IGFALS), insulin, and leptin caused considerable weight loss and growth retardation in animals. Recent data showed that DON inhibited the growth of mice by altering the levels of IGF-1 and IGFALS (Amuzie and Pestka, 2010; Voss, 2010) , induced suppressor of cytokine signaling 3 (SOCS3) (Amuzie and Pestka, 2010; Wang et al., 2012) , and disrupted the growth hormone axis (Voss, 2010) . However, DON exposure reduced the plasma insulin and leptin in obese mice (Kobayashi-Hattori et al., 2011) . In line with these observations, we hypothesized that trichothecenes inhibit the growth hormone synthesis and secretion, regulate the level of hormones such as IGF-1 and IGFALS, and cause considerable weight loss and growth retardation in animals.
Ribosome and endoplasmic reticulum (ER) are the main targets of trichothecenes (Pestka, 2010; Shi et al., 2009) . Trichothecenes induce mitogen-activated protein kinase (MAPK) activation and inflammatory responses and inhibit protein synthesis Shi et al., 2009; Zhou et al., 2003) . As most of growth hormones are proteins or polypeptides; trichothecenes suppresses these hormones by inhibiting their synthesis or by degrading them via ubiquitylation. However, evidence also showed that trichothecenes suppress these hormones by inducting proinflammatory cytokines such as interleukin-6 (IL-6). They down regulate the growth hormone receptors (GHRs) via suppression of cytokines (SOCS)-related mechanism and signal transducers (Amuzie and Pestka, 2010; Amuzie et al., 2009) and activation of transcription (STAT)-related mechanisms (Wang et al., 2012) . Hemopoietic cell kinase (Hck) and eukaryotic translation initiation factor 2-alpha kinase 2 [EIF2AK2; also known as double-stranded RNA-dependent protein kinase (PKR)] mediate the activation of MAPKs, including Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 that play crucial roles in increasing the levels of cytokines and inflammatory reactions (Zhou et al., 2003 (Zhou et al., , 2005 . Moreover, it has been suggested that trichothecene-induced EIF2AK2 and Hck may be involved in hormone suppression.
On the basis of these findings, this study investigated the levels of growth hormone 1 (Gh1) involved in cross-talk with IGF-1 and leptin, in rat pituitary adenoma GH3 cells incubated with major trichothecenes, ie, T-2 toxin, DON, and nivalenol (NIV). Potential mechanisms for growth hormone suppression were also investigated by employing an integrated transcriptomics, proteomics, and RNA interference (RNAi) approach. Understanding the mechanisms underlying trichothecene-mediated growth retardation is of vital importance to accurately assess the risk and to establish appropriate management or regulatory strategies in the future.
MATERIALS AND METHODS
Chemicals and reagents. T-2 toxin, HT-2 toxin, neosolaniol (NEO), T-2 triol, T-2 tetraol, DON, NIV, 3-(4,5-dimethylthiazol-2)-2,5-diphenyltetrazolium bromide (MTT), and dimethyl sulfoxide were purchased from Sigma (St. Louis, Missouri). SB203580, SP600125, FTS, sodium dodecyl sulfate (SDS), DL-dithiothreitol (DTT), iodoacetamide, acetonitrile, trifluoroacetic acid (TFA), pyrrolidine dithiocarbamate (PDTC), and a-cyano-4-hydroxycin namic acid (CHCA) were purchased from Santa Cruz Biotechnology (Santa Cruz, California). TRIzol was purchased from Invitrogen (Carlsbad, California), and nonlinear immobilized pH gradient (IPG) strips (18 cm, pH 3-10) were purchased from GE Healthcare Bio-Sciences (Piscataway, New Jersey). Rat growth hormone enzyme-linked immunosorbent assay (ELISA) kit was purchased from Millipore (Billerica, Massachusetts), and anti-actin antibody (ab1801), anti-P4hb antibody (ab137110), anti-Hsp60 antibody (ab46798) were purchased from Abcam (Cambridge, Massachusetts). Anti-growth hormone (T-20), antiHck (M-28), and anti-PKR (D-20) antibodies were purchased from Santa Cruz Biotechnology. Peroxidase-coupled secondary antibodies [goat anti-rabbit and anti-mouse antibodies (H þ L)] were obtained from Cell Signaling Technology (Denver, Massachusetts), and annexin V-fluorescein isothiocyanate (FITC) Apoptosis Detection Kit was purchased from BestBio (Shanghai, People's Republic of China).
Cell culture and treatments. GH3 cells (Cell Bank of Academy of Sciences, Shanghai, People's Republic of China) were cultured in Dulbecco's Modified Eagle's medium (DMEM; HyClone, Logan, Utah) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco BRL, Gaithersburg, Maryland) and 1% penicillin-streptomycin (Sigma) at 37 C in humidified atmosphere of 5% CO 2 in air. After 24 h, the culture medium was replaced by DMEM containing 1% heat-inactivated FBS and 1% penicillinstreptomycin, and the cells were incubated with or without (control) the test reagents at indicated time intervals. For inhibitor assays, inhibitors were pretreated for 45 min before being used for the treatment of toxins. GH3 cells passaged 5-15 times were used in these experiments. All the experiments were performed at least in triplicate on 3 separate occasions.
Analysis of cell viability and apoptosis. Cells were treated with different concentrations of trichothecenes (0-80 nM of T-2 toxin, 0-8 lM of DON, and 0-5 lM of NIV), were seeded in 96-well culture plates (1 Â 10 4 cells/well), and were incubated at 37 C for 4, 8, 12, and 24 h, respectively. After incubation, the cells were treated with 0.5 mg/ml MTT (100 ll/well) at 37 C for 4 h, and optical density was read using a microplate reader (Bio-Tek Instruments, Inc., Winooski, Vermont). Cell apoptosis was measured using annexin V-FITC apoptosis detection kit, as described in our previous study (Wang et al., 2012) . GH3 cells were pretreated without (control) or with DON (4 lM), T-2 toxin (40 nM), and NIV (2 lM) for 12 h. After treatment, the cells were washed twice with phosphate-buffered saline and were incubated in 300 ll binding buffer containing 3 ll annexin V-FITC and 3 ll propidium iodide at room temperature in the dark for 15 min. The stained samples were analyzed using a flow cytometer within 1 h following the manufacturer's protocol (CyAn ADP, Beckman, California).
Measurement of growth hormone by using ELISA. For measuring growth hormone, GH3 cells were seeded in 24-well plates. After incubation for 24 h, cells in the trichothecene treatment groups were treated with DON (1, 2, and 4 lM), T-2 toxin (10, 20, and 40 nM), and NIV (0.125, 1, and 2 lM) for 4, 8, and 12 h, respectively. Cells in the inhibitor treatment groups were pretreated with the inhibitors of p38 (SB203580), Ras (FTS), JNK (SP600125), ERK (PD98059), JAK (AG490), STAT (Stattic), nuclear factor kappa B (NF-jB; PDTC), and CaMKII (KN-93) for 45 min, followed by treatment with DON (4 lM) for another 4 h. After incubation, the supernatants were collected, centrifuged at 2000 rpm and 4 C for 5 min, and stored at À20 C until analysis by using rat growth hormone ELISA kit (Millipore Corp.), according to the manufacturer's instructions.
Transcriptomics Studies RNA isolation and cRNA preparation. The GH3 cells which incubated with T-2 toxin at a concentration of 10 and 40 nM for 12 h were used for Transcriptomics studies. After T-2 treatment, total RNA was isolated from the GH3 cells using Trizol Reagent (Invitrogen, Breda, The Netherlands) according to the manufacturer's protocols. After DNase I treatment, the RNA was cleaned up with the RNeasy Kit (Qiagen, Hilden, Germany) and then quantitated spectrophotometrically. Total RNA from each sample was quantified using the NanoDrop ND-1000 and RNA integrity was assessed using standard denaturing agarose gel electrophoresis. The control, 10 and 40 nM T-2 treatment groups were analyzed in triplicate by 4 Â 44K Agilent Gene Chip Rat Genome Array (#G4131F, Agilent Technologies Inc., California).
Microarray hybridization, pathway analysis, and real-time polymerase chain reaction (real-time PCR). Fragmented cRNA was individually hybridized with Gene Chip Rat Genome Array (#G4131F, Agilent Technologies Inc., California) according to the standard protocol of CapitalBio Corporation (CapitalBio, Beijing, China). Briefly, total RNA from each sample was linearly amplified and was labeled with Cy3-UTP. The labeled cRNAs were purified using RNeasy Mini Kit. Concentration and specific activity of the labeled cRNAs (pmol Cy3/lg cRNA) were measured using NanoDrop ND-1000. Next 1 lg of each labeled cRNA was fragmented by adding 11 lL 10Â blocking agent and 2.2 ll 25 Â fragmentation buffer. The cRNA samples were then heated at 60 C for 30 min and were diluted using 55 ll 2 Â GE hybridization buffer. Next, 100 ll hybridization solution was dispensed into a gasket slide and assembled to the microarray slide. The slides were incubated for 17 h at 65 C in a hybridization oven (Agilent). The hybridized arrays were washed, fixed, and scanned using Agilent DNA Microarray Scanner (part number G2505B). Agilent Feature Extraction software (version 11.0.1.1) was used to analyze the acquired array images. Quantile normalization and subsequent data processing were performed using GeneSpring GX v11.5.1 software package (Agilent Technologies). After quantile normalization of the raw data, genes showing significant differential expression were identified using volcano plot filtering and fold-change filtering. Hierarchical clustering was performed using Agilent GeneSpring GX software v11.5.1. GO and pathway analyses were performed using standard enrichment computation method.
Quantitative real-time polymerase chain reaction (PCR) was performed to validate the results of microarray analysis and to determine the expression levels of the selected genes in cells exposed to 10 and 40 nM T-2 toxin. Fold differences in expression levels were calculated using 2
ÀDDCt method. Primers and amplicon sizes are listed in Supplementary Table S1 .
Bioinformatics analysis. Disease-associated genes and proteins altered by exposure of GH3 cells to T-2 toxin were analyzed using text-mining Pathway Studio software version 7.0 (Ariadne Genomics, Inc., Rockville, Maryland) that uses a database assemble from scientific abstracts and a manually created dictionary of synonyms to recognize biological terms. The altered transcripts and proteins were converted to their corresponding homologous gene IDs in humans and were imported into the Pathway Studio software. Each identified relationship was confirmed manually by using relevant PubMed/Medline hyperlinked texts.
Proteomics Studies 2-DE and MALDI TOF/TOF analysis. GH3 cells from the control and 40 nM T-2 toxin groups (12 and 24 h, respectively) were homogenized in 1 ml lysis buffer (8 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT, 1 mM PMSF, and 1% [v/v] protease and phosphatase inhibitor cocktail). The homogenates were centrifuged at 20 000Â g for 1 h at 4 (C. Next, 2-D Clean-Up Kit (GE Healthcare, Uppsala, Sweden) was used to remove ionic interfering components from the protein extraction. Proteins in urea-containing samples were quantified using Bradford method. An aliquot (800 mg) of each protein sample, which was mixed with a rehydration buffer, was loaded onto 18-cm nonlinear IPG strips (pH 3-10) for 14 h and was electrophoresed using 12% gradient SDSpolyacrylamide gel electrophoresis (SDS-PAGE) for 5 h (1 W/gel for 1 h and 15 W/gel for 4 h). After Coomassie blue staining, the gels were scanned using GS-800 calibrated densitometer (Bio-Rad Laboratories Inc, Richmond, California, US). Twodimensional images of the gel were analyzed using PDQuest 8.0 software (Bio-Rad Laboratories Inc.). Cells in the control and 40 nM T-2 toxin (12 and 24 h) groups were analyzed in triplicate to determine consistent changes in protein expression.
Spots showing differentially expressed protein were excised and digested. The corresponding peptides were extracted twice by using 25 mM ammonium bicarbonate (TFA) in 50% ACN for 10 min and were digested overnight by using 12.5 ng/ml trypsin in 100 mM ammonium bicarbonate at 37 C. The reaction was stopped by adding 5% (v/v) TFA. The supernatants were collected and were dried using vacuum freeze drying. Peptide matrix was redissolved in 0.2% TFA. Next, 0.6 ll peptide solution was mixed with 0.6 ll matrix CHCA in 30% ACN and 0.1% TFA and was spotted on the target plate.
Proteins were identified using MALDI TOF-TOF 4800 Analyzer (AB SCIEX, Foster City, California). TOF/TOF calibration mixtures (AB SCIEX) were used to calibrate the spectrum to a mass tolerance within 150 ppm. For mass spectrometry (MS), peptide mass maps were acquired in positive reflection modes and 850-4000 m/z mass ranges were used, with 1000 laser shots per spectrum. Peptide mass fingerprint peak detection criteria were minimum signal-to-noise (S/N) ratio of 10, local noise window width mass/charge (m/z) of 250, and minimum full width at half maximum (bins) of 2.9. Maximum of 20 precursors per spot, with a minimum S/N ratio of 50, were selected for MS/MS analysis by using collision gas as ambient air, with medium pressure of 10 À6 Torr. Contaminant mass/charge (m/z) peaks originating from human keratin, trypsin autodigestion, or matrix were excluded from the MS/MS analysis. Energy of 1 kV was used for collision-induced dissociation, and 2000 acquisitions were obtained for each MS/MS spectrum. The peak detection criteria were minimum S/N ratio of 3, local noise window width (m/z) of 200, and minimum full-width half-maximum (bins) of 2.9. Automatic data analysis and database searching were performed using GPS Explorer software version 3.6 (AB SCIEX) running a mascot search algorithm (v2.2; Matrix Science, London, UK) for protein identification. Raw MS and MS/MS spectra were processed using GPS Explorer software with the following criteria: MS peak filtering mass range of 850-4000 Da, minimum S/N ratio of 10, peak density filter of 50 peaks per 200 Da, maximum 65 peaks, and MS/ MS peak filtering mass range of 60-2000 Da below each precursor mass. Searches were conducted using the following settings: digestion enzyme, trypsin; missed cleavage, 1; precursor tolerance, 100 ppm; MS/MS ion tolerance, 0.4 Da; fixed modification, carbamidomethylation of cysteine; and variable modification, oxidation of methionine. Contaminant mass/charge (m/z) peaks originating from human keratin, trypsin autodigestion, or matrix were excluded. Proteins with protein score confidence intervals (CI) above 95% (protein score, 66) were considered confident identifications. The identified proteins were then matched to specific processes or functions by searching on Gene Ontology (GO) database (http://www.geneontology.org/).
Protein extraction and Western blotting. GH3 cells in 6-well plates were incubated with DON in the presence or absence of inhibitors, according to a previously established protocol. After incubation, total proteins were extracted and were analyzed as previously described (Wang et al., 2012) . Briefly, the proteins were collected, quantified, separated by 15% SDS-PAGE, and transferred onto a polyvinylidene fluoride (PVDF) membrane (Millipore). The membranes were incubated with primary antibodies (diluted according to instruction manuals) overnight at 4 (C. After washing to remove unreacted primary antibodies, the membranes were incubated with corresponding secondary antibodies (1:5000 dilution) for 1 h. Immunoreactive bands were detected using Luminata Classico Western HRP Substrate Kit (Millipore, Bedford, MaMassachusetts, USA). Images were captured using LAS-4000 luminescent image analyzer (Fujifilm, Tokyo, Japan) depending on signal intensity.
RNAi of Hck and EIF2AK2 Transcripts
Specific small-hairpin RNAs (shRNAs) targeting Hck (NM_013185), EIF2AK2 (NM_019335), and LacZ2.1 sequences, which were not complementary to any other sequence in the rat genome, were cloned into pENTR/H1/TO entry vector. The sequences of these shRNAs were as follows: LacZ2.1, 5 0 -AAAT CGCT GATT TGTG TAGT CG-3 0 ; Hck-1, 5 0 -GGAC TTTC TCAA GAGT GAA-3 0 ; Hck-2, 5 0 -GCTA TATC CCAA GCAA TTA-3 0 ; EIF2AK2-1, 5 0 -G CAGC AGTG GTTG GAAA AGA-3 0 ; and EIF2AK2-2, 5 0 -GGAT TATA TACA CTCG AAA-3 0 . BLOCK-iT Inducible H1 RNAi Entry Vector Kit (Invitrogen, Carlsbad, California) was used to generate an entry clone that was transferred into the pLenti4/BLOCK-iT-DEST expression vector via targeted recombination by using BLOCK-iT Inducible H1 Lentiviral RNAi System (Invitrogen). The pLenti expression constructs were co-transfected with packaging plasmids into 293T producer cell line by using Lipofectamine 2000 (Invitrogen) and ViraPower Lentiviral Expression Systems (Invitrogen). Three days after the transfection, supernatant containing viral components was harvested, filtered through 0.45-lm PVDF filter, and centrifuged at 50 000Â g and 4 C for 2 h by using Beckman SW70 rotor.
Next, the lentivirus was resuspended in DMEM and was stored at À80 C. GH3 cells were infected with the lentivirus at a multiplicity of infection of 2 in the presence of 6 lg/ml polybrene. Stable bulk cultures were generated by selection with 0.2 mg/ml Zeocin for 14 days. Downregulation of Hck and EIF2AK2 levels was assessed using quantitative reverse transcriptase PCR (qRT-PCR) and Western blotting.
Statistical analyses
Statistical analysis was performed using SPSS 17.0 for Windows. All results were expressed as mean 6 standard deviation (SD). Differences between groups were assessed using 1-way analysis of variance followed by Fisher's least significance difference test. A P value of <.05 was considered significant.
RESULTS AND DISCUSSION

Relation of Trichothecenes Exposure to Growth Hormone Secretion
To identify the possible suppression of the growth hormone by trichothecenes, rat GH3 cells were treated with major trichothecenes T-2 toxin, DON, and NIV. The levels of their Gh1 mRNA and protein were determined by qRT-PCR, immunoblotting, and ELISA methods, respectively. Results from this study found that the treatment of GH3 cells with T-2 toxin (40 nM), DON (2 and 4 lM), and NIV (2 lM) significantly inhibited the transcription of the Gh1 gene (Fig. 1A) . The reduction of Gh1 protein synthesis and secretion were also found in the trichothecenes-treated cells (Figs. 1B and 1C ). The rat growth hormone level in GH3 cells supernatant was significantly suppressed in a dose-and timedependent manner. Moreover, the level of Gh1 protein in the cells was dose-dependently decreased. Up to date, known molecular targets of trichothecenes during growth retardation are IGF-1, IGFALS, insulin, and leptin (Amuzie and Pestka, 2010; Kobayashi-Hattori et al., 2011; Voss, 2010) . This study suggested that growth hormone could be another target of trichothecenes. However, limited information is available on trichothecene-induced suppression of hormones in vivo and in vitro. Therefore, an integrated transcriptional and proteomic analysis of growth hormone suppression was performed. Based on their toxicity and ability to suppress the growth hormone synthesis, the T-2 toxin (10 and 40 nM) was used in the following experiments.
T-2 Toxin-Induced Transcripts and Proteins Changes in GH3 Cell
To the best of our knowledge, this is the first study to investigate differentially expressed genes and proteins associated with growth hormone suppression induced by trichothecenes. It reproducibly identified 1044 down-regulated and 1408 upregulated transcripts in 10 nM T-2 toxin group, and 1610 downregulated and 1736 upregulated transcripts in 40 nM T-2 toxin group. Of these, 1878 induced transcripts and 1404 suppressed transcripts were already known and 921 induced transcripts and 666 suppressed transcripts were common between the 2 sampling times (Fig. 2A) . These genes were associated with protein synthesis and modification showed the highest level of alteration. Genes associated with signal transduction, stress responses, cell cycle, apoptosis, cell differentiation, cell proliferation, cell metabolism, and transport were the next most commonly annotated genes (Fig. 2B) . The list of upregulated and down-regulated genes (>2 folds) is given in Supplementary Tables S2 and S3 , respectively. Besides, the data from proteomics showed that 129 identified proteins were differentially expressed in T-2 toxin group, 48 were upregulated (Supplementary Table S4 ) and 81 were down-regulated (Supplementary Table S5 ). Of these proteins, 91 and 63 differential proteins were identified in cells treated for 12 and 24 h, respectively, while 24 differential proteins were common between the 2 sampling times (Fig. 3A) . Most of these proteins were (1) signal transducers; (2) stress-related proteins; (3) ion channel-related proteins; (4) proteins involved in transcription, translation, modification, and degradation; (5) antioxidants; (6) metabolism-related proteins, and (7) cytoskeletal proteins (Fig. 3B) .
Confirmation of transcriptomics and proteomic changes. To verify the quantification of transcription and protein changes in the study, the mRNA levels of 5 representative transcriptions, endoplasmic reticulum-golgi intermediate compartment (Ergic2), NAD(P)H dehydrogenase, quinone 1 (Nqo1), Hck, EIF2AK2, caspase 8 (CASP8) were measured by qRT-PCR, and the representative proteins disulfide isomerase (P4hb) and heat shock protein FIG. 1. Trichothecenes suppress growth hormone synthesis, storage, and secretion in GH3 cells. A, Transcription of Gh1 in GH3 cells after trichothecene treatment, as determined using qRT-PCR. B, Gh1 protein in GH3 cells after trichothecene treatment, as determined by Western blotting. C, Gh1 secreted in supernatant by GH3 cell, as determined by ELISA. All the results were expressed as mean 6 SD of 3 separate experiments performed in triplicate. Bars represent fold changes compared with control. *P < .05 and **P < .01 significantly different from control. 60 (Hsp60) were measured by Western blotting. Detection of relative up-and down-regulation of these mRNA and protein levels by qRT-PCR and immunoblot was in agreement with the transcriptomics and proteomics results (Fig. 4) .
Analysis of targeted transcripts and proteins related to hormones synthesis. Although numbers of studies on the gene expression files of trichothecenes, including T-2 toxin and deoxynivalenol, were performed in pregnant rats (Sehata et al., 2004a (Sehata et al., , b, 2005 , porcine liver (Wang et al., 2011) , mice spleen and skeletal bones (Kinser et al., 2004; Zhao et al., 2012) and cell lines in vitro (Diesing et al., 2011; Li et al., 2014) , limited data were available on the gene expression of trichothecenes on hormone synthesis. After acute DON exposure (0.1-12.5 mg/kg b.w.) in mice, the growth-related proteins, IGFALS and IGF1 were suppressed in plasma (Amuzie and Pestka, 2010) . DON exposure also reduced plasma insulin, leptin, IGF1, and IGFALS in obesity mice (Kobayashi-Hattori et al., 2011) . However, in primary mouse tracheal epithelial cells, it was found that 1000 ng/ml DON induced the growth factor Fgf5, Fgf10, and Igf1 gene expression . In this study, the results showed that the T-2 toxin suppressed the Gh1 and somatotropin levels in rat GH3 cell. Meanwhile, levels of other genes, such as GHRH and POU1F1 (associated with pituitary hormone deficiency) showed a compensatory increase. Except that, the somatostain receptor (Sstr1) was down-regulated during the treatment. In addition, the IGF binding proteins, such as IGFBP11 and IGF2BP2, as well as IGF binding protein-like 1 (IGFlr1) were induced by T-2 toxin. However, the IGF binding protein, IGFBP4, was suppressed, indicating that the T-2 toxin gave rise to a GH-IGFBP4 deficiency in the cells (Fig. 5A) . T-2 toxin regulates transcription and translation. Trichothecenes is a class of well-known protein synthesis inhibitor in eukaryotic cells. After GO analysis, the data from this present study revealed that the process which most affected by T-2 toxin was transcription and translation, consisting of about 20% of differential genes and 30% of the differential proteins. First, the T-2 toxin greatly suppressed the aminoacyl-tRNA synthetases, including Aars, Nars, Ermp1, Dars2, Cars, Lars, and Mars2 (Fig. 5B) . Together with the earlier evidences which showed T-2 toxin inhibit the reaction between puromycin and tRNAmet bound to the 80 S ribosome (Smith et al., 1975) , indicated that T-2 toxin induced transcription arrest in cells. Second, it induced the transcription of the eukaryotic translation initiation factor 2a kinase, which in turn inhibited the protein synthesis initiation by phosphorylating eIF-2a (Zhou et al., 2003 (Zhou et al., , 2005 . Meanwhile, it induced the eukaryotic translation initiation factors (eIF-3d, eIF-3g, eIF-3j, and eIF-4a2) mRNA levels ( Fig.  5C ) and eIF-3e, eIF-3g protein levels (Fig. 5D ) during the treatment. However, most recently, a research on the ribosomeassociated proteome has demonstrated that EIF3 and EIF4 induced in RAW264.7 cells during DON treatment . In addition to the ribosome-association alteration on these subunits, it was also found the eIF4G has been shown to be differentially phosphorylated in whole RAW 264.7 cells treated with DON (Pan et al., 2013) . These subunits play a key role in recruiting the pre-initiation complex to the mRNA and also form a protein bridge to the mRNA . Besides, our results have found that T-2 toxin can reduce the protein level of eukaryotic translation initiation factor 5a (Eif5a) in whole GH3 cells (Fig. 5D ). It is of great importance, as it is not absolutely essential for general protein synthesis but selectively required for translation of certain mRNAs and/or may be involved in some other aspect of cell metabolism (Kang and Hershey, 1994) . Taken together, these results strongly suggest that these translation-related factors very likely contribute to translation arrest induced by trichothecenes.
T-2 toxin impacts on the proteins' processing, folding and transportation. Besides the translation arresting induced by T-2 toxin, our results also revealed that T-2 toxin inhibited the synthesis of proteins by regulating the expression of protein folding related proteins and disturbed the protein processing and transportation. Specifically, it down regulates the quiescin Q6 sulfhydryl oxidases (QSOX1, QSOX2) transcription (Fig. 5B) and reduces the protein disulfide isomerases (Pdia3, P4hb) levels (Fig. 5D) . They directly target disulfide bond formation and protein folding (Alon et al., 2010; Nakamura and Lipton, 2011) . Moreover, differential expression of heat shock proteins (Hspa5/GRP78, Hsp90ab1, Hsp60, Hsp 70) and ubiquitylation enzymes (Ubqln1, UBE2N, and Uchl1) indicated that unfolded protein response and ER stress response were involved in T-2 toxin toxicity (Tables 1 and 2 ). Hsp90 is known to participate in the maturation of proteins, modulation of protein activity, and intracellular transport of some newly synthesized signaling transduction kinases (Prodromou et al., 1997; Wiech et al., 1992) . It is the most abundant constitutively expressed stress protein in the cytosol of eukaryotic cells. In this study, it was decreased in both mRNA and protein levels at 12 and 24 h in response to T-2 toxin. However, Wang et al. (2011) found that the mRNA level of HSP90 (HSP90aa1) was induced more than 3 times in primary porcine hepatocytes, under the treatment of T-2 toxin at the dose of 100 nM (0.05 lg/ml). Recently, it was found that the ribosome association of HSP90 was slightly induced at 5-15 min in response to DON in RAW 264.7 cell, but it dramatically decreased at 30 min research. These results suggested that the protein maturation and folding was first enhanced but finally inhibited by the toxins. In addition, the Hspa5/GRP78 showed increased association with 12 h of T-2 toxin treatment in GH3 cell. This result was in line with the results that after 30 min treatment of DON in RAW 264.7 cell, the GRP78 were greatly increased . However, it dramatically decreased after 24 h of T-2 toxin treatment. Moreover, our results found that Hsp60 was reduced in GH3 cells. Taken together, our findings indicated that the protein folding may be compensatory increase at the early stage, but it decreased at the end. However, some of chaperones, such as Hsp70, were induced during the treatment. They may help in the protein folding and signaling transduction. Finally, our results revealed some genes such as Ergic, RAB27a, and Slc29a4, were reduced during T-2 toxin treatment (Table 1 ). These differential genes were first found during T-2 toxin treatment, and they are related to the protein intercellular transport and hormone secretion (Nishioka and Haraoka, 2005; Yi et al., 2002) .
T-2 toxin impacts on stress-related signaling. Previous studies well demonstrated that the mycotoxin trichothecenes induces the inflammatory response via Hck and double-stranded RNAdependent protein kinase (PKR, also known as EIF2AK2) in mice macrophage and RAW 264.7 cell line Zhou et al., 2003) . These 2 kinases mediated activation of MAPKs, including Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 (Pestka, 2010) . In macrophages, EIF2AK2 inhibits protein synthesis initiation by phosphorylating eIF-2a, while Hck acts as a transducer of ribotoxic stress response that evokes MAPK activation and leads to apoptosis (Zhou et al., 2003 (Zhou et al., , 2005 . EIF2AK2, Hck, and p38 translocated to the 40 S ribosomal subunit and phosphorylated (Bae et al., 2010) , which then followed by MAPK activation and proinflammatory reaction in <15 min (Pestka, 2010) . From our microarray results, it was found that the Hck and EIF2AK2 were also significantly induced in GH3 cell line by T-2 toxin treatment. In addition, T-2 toxin altered the transcription of Ras-related genes (RASSF1, RASSF4, RASAl3, RASD1, and RHOH), inflammatory responseassociated genes (Traf2, IL22, and IFRD1), nuclear factor kappa B (NF-jB)-related transcripts (Nfkbil1 and Nfrkb) and Jun (Fig. 6A) . Along with observations, we hypothesized that trichothecenes suppressed growth hormone levels and Hck and EIF2AK2 played key roles in regulating the growth hormone via inflammatory response, probably via the MAPK signaling pathway. Therefore, the roles of Hck, EIF2AK2, Ras/MAPK, p38/MAPK, ERK, and JNK in growth hormone suppression were investigated. ShRNAs targeting Hck and EIF2AK2 mRNAs were successfully transfected to À/À cell lines were generated, and the efficiency was determined using qRT-PCR and Western blotting. C, Gh1 transcription in T-2 toxin-and DON-treated Hck À/À and EIF2AK2 À/À cells versus that in control. All the results are expressed as mean 6 SD of 3 separate experiments performed in triplicate. *P < .05 and **P < .01 significantly different from control.
GH3 cells, and stable cell lines were generated by Zeocin selection (Fig. 6B ). No significant difference was observed in Gh1 transcription between the control and blank clones. However, it was significantly declined in control clones after DON administration. Moreover, decrease in Gh1 transcription in both EIF2AK2-and Hck-target shRNA expression clones was significantly reversed compared with that in DON-treated controls (Fig. 6C) . Meanwhile, it was found that Ras/MAPK, p38/MAPK and JNK, but not ERK were critical for the T-2 toxin induced growth hormone suppression. Effect of DON was partially reversed by inhibitors of p38 (SB203580), Ras (FTS), and SP600125 (JNK) (Fig. 7) . These data strongly suggest that Hck/EIF2AK2-MAPKs pathway was closely associated with growth hormone synthesis. However, transient activation of MAPK is not sufficient to illustrate long-term growth retardation in animals. How these stress-related kinases work during trichothecenes-induced growth retardation should be further investigated. inhibitor of ERK. All the results are expressed as mean 6 SD of 3 separate experiments performed in triplicate. *P < .05 and **P < .01 significantly different from control.
T-2 toxin induced cell cycle arrest and apoptosis. T-2 toxin-induced cell cycle arrest and apoptosis has been demonstrated both in vivo and in vitro. It significantly induced cyclin G, cyclin D3, p21, Bax-a, and Bcl-2-related ovarian death gene product BOD-L in pregnant rats and resulted in cell apoptosis in liver, placenta, and fetal liver (Sehata et al., 2004a) . Similarly, the transcription levels of Bcl-2 associated X, caspase 1, and caspase 15 were greatly induced in primary porcine hepatocytes (Wang et al., 2011) . T-2 toxin regulates p21 and cyclin D1 transcription, exhibits cell cycle arrest, and causes cell apoptosis in RAW264.7 cells (Wang et al., 2012; Wu et al., 2014) . As shown here, regulators of both cell cycle and apoptotic pathways are differentially expressed in the GH3 cell treated with T-2 toxin. Specifically, genes with induced transcription status during T-2 toxininduced growth hormone suppression were including CCNB1IP1, GADD45, CDCA8, CDCA5, CDK5RAP1,CHOP, CASP8, PDCD7, BAG5, and BBC3 (Table 1) . And the differential proteins included prohibitin, programmed cell death protein 10 (PDCD 10), and glutathione S-transferase (Table 2) . Growth arrest and DNA-damage-inducible (GADD45g) participate in cell cycle regulation. It mainly stops the DNA replication and cell proliferation, and induces cell cycle arrest (Vairapandi et al., 2002) . Cyclin B1 interacting protein (CCNB1IP1), also called HEI10, is a member of E3 ubiquitin protein ligase. It regulates cell cycle by acting at G2/M phase (Hillier et al., 1996) . These findings are similar to our previous study in which we demonstrated that T-2 toxin mainly exhibits a G0/G1 cell cycle arrest, while DON exhibits a G2/M cell cycle arrest (Wang et al., 2012) . Probably, the cell cycle arrest and apoptosis induced by T-2 toxin would involve in growth hormone suppression in GH3 cells.
T-2 toxin impact on energy metabolism. Deregulation of cellular metabolism, especially the process of Kreb's cycle, has been suggested to occur at the mRNA and protein level during T-2 toxin-induced growth hormone suppression in GH3 cell.
Multiple genes and proteins involved in cellular metabolism were decreased, including ATP citrate lyase (Acly), pyruvate kinase isozymes M1/M2 (Pkm2), aconitate hydratase (Aco2), isocitrate dehydrogenase (NAD) subunit alpha (IDH), and malate dehydrogenase (MDH1) ( Tables 1 and 2 ). These are of great importance in Kreb's TCA cycle. In this way, weakened energy metabolism might be adverse to the synthesis and transportation of growth hormone and other proteins to and from the ribosome and ER.
Comparison of the Results of Transcriptomics and Proteomics
Finally, the differential genes which were differentially expressed in proteins were classified. Altogether, only 17 targets were found in the results of transcriptomics and proteomics (Table 3) . These targets included growth hormone (Gh1), energy metabolism enzymes [Glucose-6-phosphate 1-dehydrogenase (G6PD); Aldehyde dehydrogenase (ALDH)], redox enzymes [Glutaredoxin-1 (Glrx1); Peroxiredoxin-4 (Prdx4)], molecular chaperones [Heat shock protein HSP 90-beta (Hsp90ab1)], Peptidyl-prolyl cis-trans isomerase (FKBP4), Calmodulin, and Reticulocalbin-1 (RCN1). The time and space difference in gene transcription and protein synthesis, detectability of the 2D-MS method, the abundance and copies of the mRNA and the posttranslation processing are possible reasons for the difference in the results of the transcriptomics and proteomics study.
CONCLUSIONS
In summary, our results revealed growth hormone could be a new target of trichothecenes during growth retardation and gave a global view on the T-2 toxin-induced growth hormone suppression. Together with the depressed growth hormone levels, our results also revealed T-2 toxin inhibits gene transcription and mRNA translation, negatively regulates the protein processing and transportation, activates stress-related signaling, deregulates cellular metabolism, and induces cell cycle arrest and apoptosis. Specifically, T-2 toxin reduces the activities of aminoacyl-tRNA synthetases and adversely affects the translation initiation, by inducing the transcription of EIF2AK2 and reducing Eif5a protein levels in GH3 cells. The protein processing and folding were influenced by the declined levels of sulfhydryl oxidases, disulfide isomerases and Hsp90. Most pernicious were the induction of Hck and EIF2AK2 kinases, which activated the MAPK signaling and evoked inflammatory stress in GH3 cells. When these 2 kinases were knocked down or blocked the MAPK pathways, the growth hormone levels were 
